financetom
Business
financetom
/
Business
/
Wells Fargo sues JPMorgan over troubled $481 million real estate loan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wells Fargo sues JPMorgan over troubled $481 million real estate loan
Mar 10, 2025 11:23 AM

NEW YORK (Reuters) -Wells Fargo ( WFC ) sued JPMorgan Chase ( JPM ) on Monday to recover losses for investors in a $481 million commercial real estate loan that was allegedly based on a fraudulently inflated financial metric.

The lawsuit pits the fourth-largest U.S. bank against the largest, with Wells Fargo ( WFC ) accusing JPMorgan ( JPM ) of turning a blind eye during due diligence in pursuit of millions of dollars in fees. 

JPMorgan ( JPM ) made the loan to finance the 2019 purchase by the Chetrit Group, a private Manhattan real estate development firm, of 43 multifamily properties with 8,671 apartments in 10 U.S. states.

Wells Fargo ( WFC ), in its role as the investors' trustee, said JPMorgan ( JPM ) and Chetrit learned before the $522 million purchase closed that the seller overstated the properties' historical net operating income, a key commercial real estate metric, by 25%.

But according to the complaint in Manhattan federal court, JPMorgan ( JPM ) went ahead with the loan, knowing it would eventually be sold in pieces to unwitting investors.

The borrower defaulted in 2022 and still owes more than $285 million, while investors have lost tens of millions of dollars, Wells Fargo ( WFC ) said.

"JPM had an obligation to engage in due inquiry to determine the scope of the fraudulent reporting" after learning about the inflated metric, Wells Fargo ( WFC ) said.

"Instead, JPM plowed ahead as if nothing unusual had happened," Wells Fargo ( WFC ) added, "without even bothering to correct known errors in the numbers."

The defendants also include Meyer Chetrit, a Chetrit Group principal who provided a loan guaranty.

JPMorgan ( JPM ) and the Chetrit Group had no immediate comment.

Wells Fargo ( WFC ) wants New York-based JPMorgan ( JPM ) to repurchase the loan, less amounts the trust received from sales of underlying properties, or else pay damages for breach of contract.

Lawyers for San Francisco-based Wells Fargo ( WFC ) did not immediately respond to requests for additional comment.

The case is Wells Fargo Bank NA as trustee v JPMorgan Chase Bank NA et al, U.S. District Court, Southern District of New York, No. 25-01943.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bunge Names Leaders For Operations Post Viterra Merger
Bunge Names Leaders For Operations Post Viterra Merger
Apr 16, 2024
Bunge Global SA ( BG ) said the combined Bunge and Viterra business following the close of the proposed transaction will have Viterra CEO David Mattiske as Co-Chief Operating Officer (COO) along with Julio Garros, Bunge’s Co-President, Agribusiness. The co-COOs will oversee the commercial activities, including commodity value chains, country/regional structures, Centers of Expertise and Industrial Operations & Safety. As previously announced, the combined...
Canada's TD Bank names Matt Boss U.S. consumer banking head
Canada's TD Bank names Matt Boss U.S. consumer banking head
Apr 16, 2024
April 16 (Reuters) - Canada's TD Bank names Matt Boss as head of its consumer banking unit in the United States. ...
EXPLAINER-Why are US pharmacy benefit managers under fire?
EXPLAINER-Why are US pharmacy benefit managers under fire?
Apr 16, 2024
WASHINGTON, April 16 (Reuters) - Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month's U.S. government budget deal. Many lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play...
US FDA says counterfeit versions of Botox found in multiple states
US FDA says counterfeit versions of Botox found in multiple states
Apr 16, 2024
April 16 (Reuters) - The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that unsafe counterfeit versions of AbbVie's ( ABBV ) Botox were found in multiple states and given to consumers for cosmetic purposes. (Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved